BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33255502)

  • 1. Novel Solid Dispersions of Naphthoquinone Using Different Polymers for Improvement of Antichagasic Activity.
    Oliveira VDS; Dantas ED; Queiroz ATS; Oliveira JWF; Silva MSD; Ferreira PG; Siva FCD; Ferreira VF; Lima ÁAN
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of
    Oliveira VDS; Silva CC; de Freitas Oliveira JW; da Silva MS; Ferreira PG; da Siva FC; Ferreira VF; Barbosa EG; Barbosa CG; Moraes CB; Freitas-Junior LHG; Converti A; Lima ÁAN
    J Drug Deliv Sci Technol; 2023 Mar; 81():104229. PubMed ID: 36776572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, Physicochemical Characterization and In Vitro Anti-Inflammatory Activity of Solid Dispersions of α,β Amyrin Isolated from Protium Oilresin.
    da Silva Júnior WF; Pinheiro JGO; de Menezes DLB; E Silva NES; de Almeida PDO; Lima ES; da Veiga Júnior VF; de Azevedo EP; de Lima ÁAN
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28891943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F; Trivino A; Prasad D; Chauhan H
    Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
    Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization.
    Yousaf AM; Malik UR; Shahzad Y; Mahmood T; Hussain T
    J Pharm Anal; 2019 Feb; 9(1):34-39. PubMed ID: 30740255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
    Gorajana A; Kit WW; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
    Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of solid dispersions based on 3- (2,6-difluorobenzyl) -5- (5-bromo-1H-indol-3-ylmethylene) thiazolidine-2,4-dione for schistosomicidal treatment.
    Paulino S; Santos L; Rabello M; da Silva P; Oliveira J; Lima MDC; Rocha T; Albuquerque M; Santos V; Alves L; Brayner F; Gomes T; Aires A; Neto PR; Silva R
    Exp Parasitol; 2023 May; 248():108455. PubMed ID: 36764643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers.
    Gorajana A; Rajendran A; Yew LM; Dua K
    Int J Pharm Investig; 2015; 5(3):171-8. PubMed ID: 26258059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation.
    Xiong X; Zhang M; Hou Q; Tang P; Suo Z; Zhu Y; Li H
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110012. PubMed ID: 31546459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
    Zoghbi A; Geng T; Wang B
    AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.
    Jun SW; Kim MS; Jo GH; Lee S; Woo JS; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1529-37. PubMed ID: 16354397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.